Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Artificial Intelligence (AI) In Drug Discovery Market Forecast: What Market Value Is Expected By 2030?

The market for artificial intelligence in cancer diagnostics has seen rapid expansion in recent years, with its value projected to rise from $0.79 billion in 2025 to $0.96 billion in 2026, reflecting a compound annual growth rate (CAGR) of 20.2%. This historical growth has been driven by factors such as the limited integration of AI into early diagnostic processes, a continued dependence on conventional imaging methods, a global increase in cancer incidence, a growing need for technologies that enable early detection, and the proliferation of diagnostic facilities.

The market for artificial intelligence in cancer diagnostics is projected to experience significant expansion over the coming years, reaching an estimated valuation of $1.97 billion by 2030, driven by a compound annual growth rate of 19.9%. This anticipated growth during the forecast period is fueled by progress in deep learning and machine learning algorithms, the proliferation of AI-enhanced imaging systems, deeper incorporation of predictive analytics into healthcare, increased funding for digital health innovations, and strengthened partnerships between AI developers and medical institutions. Key developments shaping the forecast period encompass the wider uptake of AI-based imaging and diagnostic tools, the integration of predictive analytics into cancer screening processes, the growing utilization of AI for tumor identification and categorization, the expansion of AI-powered monitoring and follow-up systems, and a rise in cooperative efforts between hospitals and AI solution providers.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3411&type=smp

Artificial Intelligence (AI) In Drug Discovery Market Growth Factors Supporting Long-Term Expansion

The rising incidence of cancer is anticipated to drive the expansion of artificial intelligence within the cancer diagnostics market in the coming years. Cancer encompasses a range of diseases characterized by abnormal cell growth that can potentially invade or spread to other areas of the body. The incorporation of AI into cancer care is designed to boost efficiency, accuracy, and personalized treatment approaches, ultimately leading to better outcomes for patients. For example, in May 2024, the National Cancer Institute, a U.S.-based government agency, reported that around 2 million new cancer diagnoses are expected in the United States in 2024, with over 611,000 deaths projected. By 2040, the global number of new cancer cases is estimated to reach 29.9 million, while cancer-related deaths are forecast to climb to 15.3 million. Consequently, the growing prevalence of cancer is fueling the advancement of artificial intelligence in the cancer diagnostics market.

#Artificial Intelligence (AI) In Drug Discovery Market Segment Landscape And Growth Potential

The ai in cancer diagnostics market covered in this report is segmented –

1) By Component: Software Solutions, Hardware, Services

2) By Cancer Type: Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer And Cervical Cancer, Prostate And Colorectal Cancer, Other Cancer Types

3) By Application: Screening And Diagnosis, Tumor Identification, Monitoring

4) By End User: Hospitals, Diagnostic Centers, Medical Research Institutes

Subsegments:

1) By Software Solutions: Machine Learning Software, Deep Learning Software, Image Analysis Software

2) By Hardware: AI-Powered Imaging Systems, Diagnostic Devices

3) By Services: AI Integration Services, Consulting And Training Services, Support And Maintenance Services

Artificial Intelligence (AI) In Drug Discovery Market Industry Trends Shaping Future Revenue Growth

Companies leading the AI in cancer diagnostics market are experiencing notable expansion, fueled by progress in AI-enabled digital pathology systems designed for cancer detection. These systems employ artificial intelligence algorithms to identify cancerous and diagnostic features across various tissue types, delivering precise and timely diagnoses, aiding in case prioritization, and ensuring consistent results. For example, in November 2023, Dedalus, in collaboration with Ibex Medical Analytics, a European health software firm, introduced a comprehensive End-to-End AI-driven digital pathology solution for cancer diagnosis throughout Europe. This innovation is intended to boost accuracy, provide AI-assisted decision support, streamline reporting processes, optimize laboratory workflows, and strengthen diagnostic certainty.

Artificial Intelligence (AI) In Drug Discovery Market Competitive Landscape: Who Are The Leading Companies?

Major companies operating in the ai in cancer diagnostics market are Microsoft Corporation, IBM Corporation, Verily Life Sciences LLC, Tempus Labs Inc, Guardant Health Inc, Lunit Inc, Paige AI Inc, Viz.ai Inc, Enlitic Inc, Ibex Medical Analytics Ltd, Kheiron Medical Technologies Limited, CureMetrix Inc, CancerIQ Inc, MultiplAI Health Inc, Freenome Holdings Inc, SkinVision B V, Owkin Inc, Imagen Technologies Inc, Cyrcadia Health Inc, Oncora Medical Inc, Xilis Inc

Access The Complete Artificial Intelligence (AI) In Drug Discovery Market Report:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-drug-discovery-global-market-report

Artificial Intelligence (AI) In Drug Discovery Market Geographic Landscape: Which Region Dominates Industry Growth?

North America was the largest region in the artificial intelligence in cancer diagnostics market in 2025. The regions covered in the ai in cancer diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Artificial Intelligence (AI) In Drug Discovery Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=28918&type=smp

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model